Belete Ayele Desimmie
Belete Ayele Desimmie
1Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Laboratory for Molecular Virology and Gene Therapy, Louvain, Flanders Belgium
6Present Address: Viral Mutation Section, HIV Drug Resistance Program, Center for Cancer Research, National Cancer Institute, Frederick, MD USA
1,6,#,
Caroline Weydert
Caroline Weydert
1Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Laboratory for Molecular Virology and Gene Therapy, Louvain, Flanders Belgium
1,#,
Rik Schrijvers
Rik Schrijvers
1Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Laboratory for Molecular Virology and Gene Therapy, Louvain, Flanders Belgium
1,
Sofie Vets
Sofie Vets
1Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Laboratory for Molecular Virology and Gene Therapy, Louvain, Flanders Belgium
1,
Jonas Demeulemeester
Jonas Demeulemeester
1Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Laboratory for Molecular Virology and Gene Therapy, Louvain, Flanders Belgium
1,
Paul Proost
Paul Proost
2KU Leuven, Laboratory of Molecular Immunology, Rega Institute, Louvain, Flanders Belgium
2,
Igor Paron
Igor Paron
3Department of Proteomics and Signal Transduction, Max-Planck Institute of Biochemistry, 82152 Martinsried, Germany
3,
Jan De Rijck
Jan De Rijck
1Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Laboratory for Molecular Virology and Gene Therapy, Louvain, Flanders Belgium
1,
Jan Mast
Jan Mast
4Veterinary and Agrochemical Research Centre CODA-CERVA, Brussels, Belgium
4,
Norbert Bannert
Norbert Bannert
5Robert Koch Institute, Centre for HIV and Retrovirology, Berlin, Germany
5,
Rik Gijsbers
Rik Gijsbers
1Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Laboratory for Molecular Virology and Gene Therapy, Louvain, Flanders Belgium
1,
Frauke Christ
Frauke Christ
1Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Laboratory for Molecular Virology and Gene Therapy, Louvain, Flanders Belgium
1,
Zeger Debyser
Zeger Debyser
1Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Laboratory for Molecular Virology and Gene Therapy, Louvain, Flanders Belgium
1,✉
1Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Laboratory for Molecular Virology and Gene Therapy, Louvain, Flanders Belgium
2KU Leuven, Laboratory of Molecular Immunology, Rega Institute, Louvain, Flanders Belgium
3Department of Proteomics and Signal Transduction, Max-Planck Institute of Biochemistry, 82152 Martinsried, Germany
4Veterinary and Agrochemical Research Centre CODA-CERVA, Brussels, Belgium
5Robert Koch Institute, Centre for HIV and Retrovirology, Berlin, Germany
6Present Address: Viral Mutation Section, HIV Drug Resistance Program, Center for Cancer Research, National Cancer Institute, Frederick, MD USA
© The Author(s) 2020
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.